Adult stem cells for cardiac tissue engineering
- PMID: 20709074
- DOI: 10.1016/j.yjmcc.2010.08.009
Adult stem cells for cardiac tissue engineering
Abstract
Cell therapy and tissue engineering attract increasing attention as a potential approach for cardiac repair. Adult stem cells from autologous origin are a practically safe and appealing source for cell-based regenerative therapies that may hold realistic clinical potential. A plethora of interesting concepts have been introduced aiming at regenerating ischemic myocardium through adult stem cell-based bioartificial cardiac tissue supplements. Yet, current pre-clinical concepts have not reached translational applicability, and successes are only episodic. This review will provide a brief overview of the latest concepts and breakthroughs in the emerging field of cardiac adult stem cell-based tissue engineering, and discuses the challenges that this field needs to overcome to achieve realistic therapeutic translation into the clinical arena. This article is part of a special issue entitled, "Cardiovascular Stem Cells Revisited".
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Cellular cardiac regenerative therapy in which patients?Expert Rev Cardiovasc Ther. 2009 Aug;7(8):911-9. doi: 10.1586/erc.09.84. Expert Rev Cardiovasc Ther. 2009. PMID: 19673669 Review.
-
Embryonic and embryonic-like stem cells in heart muscle engineering.J Mol Cell Cardiol. 2011 Feb;50(2):320-6. doi: 10.1016/j.yjmcc.2010.10.027. Epub 2010 Oct 30. J Mol Cell Cardiol. 2011. PMID: 21040727 Review.
-
Cell and tissue engineering and clinical applications: an overview.Biomed Mater Eng. 2006;16(4 Suppl):S3-S18. Biomed Mater Eng. 2006. PMID: 16823111 Review.
-
Embryonic and adult stem cell therapy.J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S336-44. doi: 10.1016/j.jaci.2009.09.032. Epub 2010 Jan 12. J Allergy Clin Immunol. 2010. PMID: 20061008 Review.
-
Immunomodulatory properties of human periodontal ligament stem cells.J Cell Physiol. 2009 Jun;219(3):667-76. doi: 10.1002/jcp.21710. J Cell Physiol. 2009. PMID: 19160415
Cited by
-
Modified mRNA as a Treatment for Myocardial Infarction.Int J Mol Sci. 2023 Mar 1;24(5):4737. doi: 10.3390/ijms24054737. Int J Mol Sci. 2023. PMID: 36902165 Free PMC article. Review.
-
Regenerative Engineering: Current Applications and Future Perspectives.Front Surg. 2021 Nov 3;8:731031. doi: 10.3389/fsurg.2021.731031. eCollection 2021. Front Surg. 2021. PMID: 34805257 Free PMC article. Review.
-
The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells.Stem Cells Dev. 2013 Feb 15;22(4):654-67. doi: 10.1089/scd.2012.0181. Epub 2012 Nov 7. Stem Cells Dev. 2013. PMID: 22994322 Free PMC article.
-
Myocardial regeneration of the failing heart.Heart Fail Rev. 2013 Nov;18(6):815-33. doi: 10.1007/s10741-012-9348-5. Heart Fail Rev. 2013. PMID: 23001638 Review.
-
Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling.Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E309-16. doi: 10.1073/pnas.1115083109. Epub 2012 Jan 5. Proc Natl Acad Sci U S A. 2012. PMID: 22223664 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources